Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127090410> ?p ?o ?g. }
- W3127090410 endingPage "2333" @default.
- W3127090410 startingPage "2321" @default.
- W3127090410 abstract "Background Community use of epinephrine for the treatment of anaphylaxis is low. Knowledge of rates of epinephrine use in the pre–hospital setting along with identification of barriers to its use will contribute to the development of policies and guidelines. Objectives A search was conducted on PubMed and Embase in April 2020. Our systematic review focused on 4 domains: (1) epinephrine use in the pre–hospital setting; (2) barriers to epinephrine use in the pre–hospital setting; (3) cost evaluation and cost-effectiveness of epinephrine use; and (4) programs and strategies to improve epinephrine use during anaphylaxis. Methods Two meta-analyses with logit transformation were conducted to: (1) calculate the pooled estimate of the rate of epinephrine use in the pre–hospital setting among cases of anaphylaxis and (2) calculate the pooled estimate of the rate of biphasic reactions among all cases of anaphylaxis. Results Epinephrine use in the pre–hospital setting was significantly higher for children compared with adults (20.98% [95% confidence interval (CI): 16.38%, 26.46%] vs 7.17% [95% CI: 2.71%, 17.63%], respectively, P = .0027). The pooled estimate of biphasic reactions among all anaphylaxis cases was 3.92% (95% CI: 2.88%, 5.32%). Our main findings indicate that pre–hospital use of epinephrine in anaphylaxis remains suboptimal. Major barriers to the use of epinephrine were identified as low prescription rates of epinephrine autoinjectors and lack of stock epinephrine in schools, which was determined to be cost-effective. Finally, in reviewing programs and strategies, numerous studies have engineered effective methods to promote adequate and timely use of epinephrine. Conclusion The main findings of our study demonstrated that across the globe, prompt epinephrine use in cases of anaphylaxis remains suboptimal. For practical recommendations, we would suggest considering stock epinephrine in schools and food courts to increase the use of epinephrine in the community. We recommend use of pamphlets in public areas (ie, malls, food courts, etc.) to assist in recognizing anaphylaxis and after that with prompt epinephrine administration, to avoid the rare risk of fatality in anaphylaxis cases. Community use of epinephrine for the treatment of anaphylaxis is low. Knowledge of rates of epinephrine use in the pre–hospital setting along with identification of barriers to its use will contribute to the development of policies and guidelines. A search was conducted on PubMed and Embase in April 2020. Our systematic review focused on 4 domains: (1) epinephrine use in the pre–hospital setting; (2) barriers to epinephrine use in the pre–hospital setting; (3) cost evaluation and cost-effectiveness of epinephrine use; and (4) programs and strategies to improve epinephrine use during anaphylaxis. Two meta-analyses with logit transformation were conducted to: (1) calculate the pooled estimate of the rate of epinephrine use in the pre–hospital setting among cases of anaphylaxis and (2) calculate the pooled estimate of the rate of biphasic reactions among all cases of anaphylaxis. Epinephrine use in the pre–hospital setting was significantly higher for children compared with adults (20.98% [95% confidence interval (CI): 16.38%, 26.46%] vs 7.17% [95% CI: 2.71%, 17.63%], respectively, P = .0027). The pooled estimate of biphasic reactions among all anaphylaxis cases was 3.92% (95% CI: 2.88%, 5.32%). Our main findings indicate that pre–hospital use of epinephrine in anaphylaxis remains suboptimal. Major barriers to the use of epinephrine were identified as low prescription rates of epinephrine autoinjectors and lack of stock epinephrine in schools, which was determined to be cost-effective. Finally, in reviewing programs and strategies, numerous studies have engineered effective methods to promote adequate and timely use of epinephrine. The main findings of our study demonstrated that across the globe, prompt epinephrine use in cases of anaphylaxis remains suboptimal. For practical recommendations, we would suggest considering stock epinephrine in schools and food courts to increase the use of epinephrine in the community. We recommend use of pamphlets in public areas (ie, malls, food courts, etc.) to assist in recognizing anaphylaxis and after that with prompt epinephrine administration, to avoid the rare risk of fatality in anaphylaxis cases." @default.
- W3127090410 created "2021-02-15" @default.
- W3127090410 creator A5003237628 @default.
- W3127090410 creator A5008219384 @default.
- W3127090410 creator A5017402473 @default.
- W3127090410 creator A5045886303 @default.
- W3127090410 creator A5046996095 @default.
- W3127090410 creator A5048737172 @default.
- W3127090410 creator A5051803014 @default.
- W3127090410 creator A5052776302 @default.
- W3127090410 creator A5075790767 @default.
- W3127090410 creator A5077764333 @default.
- W3127090410 creator A5080943091 @default.
- W3127090410 creator A5080962883 @default.
- W3127090410 date "2021-06-01" @default.
- W3127090410 modified "2023-10-16" @default.
- W3127090410 title "Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis" @default.
- W3127090410 cites W1019595723 @default.
- W3127090410 cites W1488650573 @default.
- W3127090410 cites W1490512113 @default.
- W3127090410 cites W1505033677 @default.
- W3127090410 cites W1556769515 @default.
- W3127090410 cites W1825908953 @default.
- W3127090410 cites W1897189358 @default.
- W3127090410 cites W1914971547 @default.
- W3127090410 cites W1963222493 @default.
- W3127090410 cites W1976291431 @default.
- W3127090410 cites W1977109638 @default.
- W3127090410 cites W1982398000 @default.
- W3127090410 cites W1987014131 @default.
- W3127090410 cites W1989696312 @default.
- W3127090410 cites W1990906702 @default.
- W3127090410 cites W1996129221 @default.
- W3127090410 cites W1996956421 @default.
- W3127090410 cites W2000380646 @default.
- W3127090410 cites W2020413996 @default.
- W3127090410 cites W2024742671 @default.
- W3127090410 cites W2032720050 @default.
- W3127090410 cites W2042189837 @default.
- W3127090410 cites W2047004129 @default.
- W3127090410 cites W2047936548 @default.
- W3127090410 cites W2048316653 @default.
- W3127090410 cites W2051807506 @default.
- W3127090410 cites W2052951012 @default.
- W3127090410 cites W2057455867 @default.
- W3127090410 cites W2070220493 @default.
- W3127090410 cites W2070437343 @default.
- W3127090410 cites W2070664794 @default.
- W3127090410 cites W2083539768 @default.
- W3127090410 cites W2092442653 @default.
- W3127090410 cites W2095700241 @default.
- W3127090410 cites W2100544795 @default.
- W3127090410 cites W2108793950 @default.
- W3127090410 cites W2109263862 @default.
- W3127090410 cites W2109533347 @default.
- W3127090410 cites W2112891753 @default.
- W3127090410 cites W2116202312 @default.
- W3127090410 cites W2118587943 @default.
- W3127090410 cites W2121096288 @default.
- W3127090410 cites W2122227662 @default.
- W3127090410 cites W2130654971 @default.
- W3127090410 cites W2132484301 @default.
- W3127090410 cites W2137689065 @default.
- W3127090410 cites W2150122864 @default.
- W3127090410 cites W2154718537 @default.
- W3127090410 cites W2154957007 @default.
- W3127090410 cites W2166183729 @default.
- W3127090410 cites W2212059635 @default.
- W3127090410 cites W2230722041 @default.
- W3127090410 cites W225663694 @default.
- W3127090410 cites W2257840317 @default.
- W3127090410 cites W2265059873 @default.
- W3127090410 cites W2275159250 @default.
- W3127090410 cites W2280545944 @default.
- W3127090410 cites W2287669467 @default.
- W3127090410 cites W2314515460 @default.
- W3127090410 cites W2335963846 @default.
- W3127090410 cites W2342048632 @default.
- W3127090410 cites W2412728662 @default.
- W3127090410 cites W2413590696 @default.
- W3127090410 cites W2418305011 @default.
- W3127090410 cites W2436697801 @default.
- W3127090410 cites W2460353733 @default.
- W3127090410 cites W2512237923 @default.
- W3127090410 cites W2530951444 @default.
- W3127090410 cites W2551982974 @default.
- W3127090410 cites W2559542498 @default.
- W3127090410 cites W2566349857 @default.
- W3127090410 cites W2576854345 @default.
- W3127090410 cites W2577017868 @default.
- W3127090410 cites W2582190913 @default.
- W3127090410 cites W2587382431 @default.
- W3127090410 cites W2592077724 @default.
- W3127090410 cites W2601490445 @default.
- W3127090410 cites W2602353828 @default.
- W3127090410 cites W2604691607 @default.
- W3127090410 cites W2606139769 @default.
- W3127090410 cites W2606556312 @default.